The U.S. government has ordered an additional 1.25 million doses of casirivimab and imdevimab antibody cocktail against coronavirus from Regeneron Pharmaceuticals, which will be delivered by mid-2021. Thus, the total supply of the drug under the order of the U.S. government will amount to more than 1.5 million doses.